According to Dr. Anthony Fauci the Reopening of the US Economy Would Endanger People’s Heath

15 Years Ago Chloroquine Was Recommended by the CDC as "A potent inhibitor of SARS Coronavirus". Why is Fauci Blocking It?


Anthony Fauci, director of the IHSS  is playing a “blame game”

He wants the lockdown to continue, no reopening of the US economy because that would endanger people’s health.

Dr. Fauci intimates that hydroxychloroquine and chloroquine are dangerous. The evidence is anecdotical, says Fauci. The corporate media presents it as a untested drug.

“The only tool we have right now for fighting the coronavirus is social distancing” says Dr. Fauci. And of course confinement, “stay at home”. Neither of these “recommendations” are medical solutions, i.e. drugs which can be used to prevent and inhibit the infection.

Fauci is opposed to the treatment of COVID-19 using chloroquine.  What he wants is for all of us to be vaccinated.

According to CNN, Trump is to blame:

Trump has been pressing federal health officials to make the drugs — hydroxychloroquine and chloroquine — more widely available, despite little reliable evidence that they are effective at treating the virus. (emphasis added)

 “Fauci says chloroquine has not been studied on coronavirus”.

What Fauci fails to mention is that Chloroquine was “studied” and tested fifteen years ago by the CDC as a drug to be used against coronavirus infections. 

According to the NYT,

The federal agency led by Dr. Anthony Fauci issued guidelines on  [April 21] that stated there is no proven drug for treating coronavirus patients” (emphasis added)

The report echoed what frustrated doctors already know: Not enough is known about the highly infectious virus or how to combat it.

“No proven drug”: “Not Enough Known”. Nonsensical and irresponsible statements.

Chloroquine was used in 2002 and tested against SARS-1 coronavirus in a study under the auspices of the CDC published in the Virology Journal.

An August 2005 report in the peer reviewed Virology Journal (summary below) was published in 2005.

The main conclusion of the article was that:  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. It was used in the SARS-1 outbreak in 2002. It had the endorsement of the CDC.


Martin J VincentEric BergeronSuzanne BenjannetBobbie R Erickson

Pierre E RollinThomas G Ksiazek,Nabil G SeidahStuart T Nichol

Scroll down for excerpts of the article in the Virology Journal published by BioMed Central. Access to the complete article. 

The main author Dr. Martin J. Vincent together with several of his colleagues were affiliated with the Special Pathogens Branch of the Atlanta based CDC together with co-authors from a Montreal based partner research institution.  The main conclusions of this study are that Chloroquine is a tested drug and can be used for SARS-corona virus infections:

Dr. Anthony Fauci is not proposing a treatment which can be applied against COVID-19. What he is saying is that there is no treatment.
What he is doing is blocking a drug which had been endorsed by the CDC 15 years ago for treatment of SARS-1 Coronavirus. More recently, it has been used extensively in a number of countries in relation to the SARS-2 Coronavirus or SARS-COV2 (COVID-19) outbreak. The impacts of these treatments are subject to controversy, with systematic attempts to disparage the use of chloroquine.
It was also endorsed by several Chinese virologists. (See below). A peer reviewed report in  The Lancet confirms the use of  chloroquine and hydroxychloroquine in China:
The drug was rapidly pushed to clinical testing as an experimental treatment in China; on Feb 15, 2020, it was included in the sixth version of the COVID-19 treatment guidelines by the National Health Commission of the People’s Republic of China. This guideline established the use of chloroquine nationwide for patients with COVID-19, at a recommended adult dose of 500 mg twice per day for no more than 10 days. 1
Dr. Antony Fauci has not put forth a preventive or effective treatment of the COVID-19. Fauci’s statement to the effect that there is no cure for CIVID-19 borders on ridicule. COVID-19 is a corona virus which triggers pneumonia and respiratory tract infections, for which there are several known cures.
For those who are sceptical, read Dr. Anthony Fauci’s  peer reviewed article on SARS-COV2 together with co-authors Clifford Lane and CDC Director Robert Redfield  published on February 28, 2020 in The New England Journal of Medicine.


According to the WHO, “The most commonly reported symptoms [COV-19] included fever, dry cough, and shortness of breath, and most patients (80%) experienced mild illness.”  


Dr. Fauci broadly acknowledges and explains the WHO definition of  COVID in his peer reviewed NEJM article. His media hype statements however are “misleading”.

And Here is the Hype of Dr. Fauci: 

The Hill

The Vaccine

Dr. Fauci is currently pushing for the development of a multibillion dollar vaccine on behalf of Big Pharma and the Gates Foundation. He is in conflict of interest. And that vaccine is far more dangerous than chloroquine.



For further details on the current SARS-2 coronavirus (alias COVID-19) as well as its relationship to SARS-1 coronavirus, see the peer reviewed  article by Anthony Fauci and co-authors Clifford Lane and CDC Director Robert Redfield  published in March issue  of The New England Journal of Medicine

Excerpt from the VJ article entitled  

Chloroquine is A potent inhibitor of SARS Coronavirus Infection and Spread

Martin J VincentEric BergeronSuzanne BenjannetBobbie R EricksonPierre E RollinThomas G Ksiazek,Nabil G SeidahStuart T Nichol 


We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage. In addition to the well-known functions of chloroquine such as elevations of endosomal pH, the drug appears to interfere with terminal glycosylation of the cellular receptor, angiotensin-converting enzyme 2. This may negatively influence the virus-receptor binding and abrogate the infection, with further ramifications by the elevation of vesicular pH, resulting in the inhibition of infection and spread of SARS CoV at clinically admissible concentrations.


Chloroquine is effective in preventing the spread of SARS CoV in cell culture. Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection. In addition, the indirect immunofluorescence assay described herein represents a simple and rapid method for screening SARS-CoV antiviral compounds.

Read more here (complete article) 


 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

M Wang, R Cao, L Zhang, X Yang, J Liu, M Xu, Z Shi… – Cell research, 2020 –

In December 2019, a novel pneumonia caused by a previously unknown pathogen emerged
in Wuhan, a city of 11 million people in central China. The initial cases were linked to
exposures in a seafood market in Wuhan. 1 As of January 27, 2020, the Chinese authorities …

Cited by 1137 All 8 versions

In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS …

X Yao, F Ye, M Zhang, C Cui, B Huang… – Clinical Infectious …, 2020 –

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke
out in 2019 and subsequently spread worldwide. Chloroquine has been sporadically used
in treating SARS-CoV-2 infection. Hydroxychloroquine shares the same mechanism of …


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research

About the author:

Michel Chossudovsky is an award-winning author, Professor of Economics (emeritus) at the University of Ottawa, Founder and Director of the Centre for Research on Globalization (CRG), Montreal, Editor of Global Research.  He has taught as visiting professor in Western Europe, Southeast Asia, the Pacific and Latin America. He has served as economic adviser to governments of developing countries and has acted as a consultant for several international organizations. He is the author of eleven books including The Globalization of Poverty and The New World Order (2003), America’s “War on Terrorism” (2005), The Global Economic Crisis, The Great Depression of the Twenty-first Century (2009) (Editor), Towards a World War III Scenario: The Dangers of Nuclear War (2011), The Globalization of War, America's Long War against Humanity (2015). He is a contributor to the Encyclopaedia Britannica.  His writings have been published in more than twenty languages. In 2014, he was awarded the Gold Medal for Merit of the Republic of Serbia for his writings on NATO's war of aggression against Yugoslavia. He can be reached at [email protected]

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected] contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]